{"nct_id":"NCT06140524","title":"A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2024-09-16","start_date_type":"ACTUAL","primary_completion_date":"2032-05-18","primary_completion_date_type":"ESTIMATED","completion_date":"2032-05-18","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["REGN"]}